- Published at
- by investing.com
positive
positive
Telo Genomics Presents New Performance Data for Its Smoldering Myeloma Prognostic Test By Investing.com
Telo Genomics Presents New Performance Data for Its Smoldering Myeloma Prognostic Test
News for Telo Genomics Corp. (TELO.V)
- Published at
- by globenewswire.com
mixedmixedMultiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030
PALM BEACH, Fla., Jan. 30, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - Recent reports show that the Multiple myeloma Diagnostic market will...- Published at
- by marketscreener.com
positivepositiveTelo Genomics Launches Physician Experience Program in the United States
Telo Genomics Corp. , , an emerging molecular testing platform provider leveraging the power of telomeres, is excited to announce the initiation of their Physician Experience Program - SMART . ...- Published at
- by investorideas.com
positivepositiveBiotech Stock News: Telo Genomics (TSXV: TELO) Launches Clinical Study of Drug Resistance Test for Multiple Myeloma
Toronto, Ontario - July 13, 2022 (Newsfile Corp.) (Investorideas.com Newswire) Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "TELO") is plea...- Published at
- by marketscreener.com
positivepositiveTelo Genomics Participates in the 18th International Myeloma Society Workshop 2021
Telo Genomics Corp. is pleased to announce that it is participating in the 18th International Myeloma Society Workshop 2021 taking place in Vienna, Austria between September 8th - 11th. Telo... | September 9, 2021- Published at
- by marketscreener.com
positivepositiveTelo Genomics Engages Clinical and Regulatory Affairs Veteran to Lead the Company's ISO 15189 Certification & CLIA Laboratory Accreditation Undertaking
Telo Genomics Corp. is pleased to announce that the Company has entered into an agreement with the clinical laboratory veteran Mark Stene, Founder & President of MyClinLab® LLC, Austin,... | August 9, 2021- Published at
- by markets.businessinsider.com
mixedmixedTSX Venture Exchange Stock Maintenance Bulletins
VANCOUVER, BC, July 8, 2021 /CNW/ - TSX VENTURE COMPANIESA.I.S. RESOURCES LIMITED ('AIS')BULLETIN TYPE: CUSIP ChangeBULLETIN DATE: July 8, 2021T...- Published at
- by marketscreener.com
positivepositiveTelo Genomics Announces Private Placement of Units
Telo Genomics Corp. is pleased to announce a non-brokered private placement of units at a price of $0.50 per Unit for gross proceeds of $1,500,000 . Each Unit will consist of one common share of... | June 18, 2021- Published at
- by marketscreener.com
positivepositiveTelo Genomics Announces AGM Voting Results and Provides Corporate Update
Telo Genomics Corp. is pleased to announce the results of its recent annual general shareholders meeting held on March 04, 2021 in Toronto, ON. The Company is also pleased to provide a corporate... | March 24, 2021